Healthcare Ethics and Gardasil: HPV Vaccine Debate
This paper examines the ethical dimensions surrounding Gardasil, Merck's vaccine targeting the two strains of human papillomavirus (HPV) responsible for 70% of cervical cancers in the United States. The paper draws an analogy between HPV vaccination and established mandatory childhood immunizations for polio and measles, while identifying five key concerns: the accelerated FDA approval process, the need for longer clinical trials, potential conflicts of interest on the FDA advisory committee, the high cost per life saved, and the disproportionate global burden of HPV in less developed countries. The paper concludes with a qualified endorsement of mandatory HPV vaccination, contingent on these concerns being addressed, and calls for government funding and profit limitations on vaccine sales.
- Introduction: HPV and the Case for Vaccination: Analogizes HPV vaccine to established childhood immunizations
- Key Concerns About Gardasil's Approval and Promotion: FDA process, conflicts of interest, and lobbying concerns
- Cost-Effectiveness and Global Equity Considerations: Cost per life saved and global access disparities
- Conclusion and Policy Recommendations: Conditional endorsement with funding and profit-limit proposals
✍️ How to write this paper — guide, tools & examples ▾
What makes this paper effective
- The paper uses a clear analogical argument, comparing HPV vaccination to well-accepted mandatory childhood immunizations like polio and measles, which grounds the policy recommendation in established precedent.
- The numbered enumeration of concerns provides logical clarity and makes the ethical objections easy to follow, even in a short-form essay format.
- The paper balances an overall supportive stance on vaccination with substantive acknowledgment of counterarguments, demonstrating intellectual honesty and nuanced ethical reasoning.
Key academic technique demonstrated
This paper demonstrates the technique of qualified endorsement: rather than advocating unconditionally for or against mandatory vaccination, the author articulates specific conditions that must be met before the policy is justified. This approach models careful applied ethics reasoning, where a conclusion is tied explicitly to the resolution of identified concerns.
Structure breakdown
The paper opens with a principled argument in favor of HPV vaccination by analogy to existing childhood immunization programs. It then pivots to enumerate five concrete ethical and practical objections — covering regulatory, financial, political, and global equity dimensions. It closes with a conditional policy recommendation that synthesizes both sides, advocating for mandatory vaccination alongside government funding and profit controls. The structure mirrors a classic problem–counterargument–resolution format appropriate for applied ethics writing.
Introduction: HPV and the Case for Vaccination
Recommendations about widespread public inoculation against the two strains of human papillomavirus (HPV) responsible for 70% of cervical cancers every year in the United States is probably a good idea. In principle, it is not fundamentally different from other mandatory inoculations administered to school-age children, such as those for polio and measles at ages five or six. Like those deadly childhood diseases, HPV is also deadly, accounting for the deaths of more than one third of the approximately 10,000 women diagnosed with cervical cancer each year. Also like polio, HPV is a childhood disease with severe long-term consequences. The only real difference is that HPV remains, in effect, dormant until adulthood.
Key Concerns About Gardasil's Approval and Promotion
On the other hand, there are several potential issues warranting serious inquiry before implementing Merck's suggestions for widespread inoculation using its new vaccine, Gardasil. First, the drug was rushed through the Food and Drug Administration (FDA) approval process. Second, critics point out that longer clinical trials would be more appropriate before making a decision about mandatory vaccination. Third, two members of the FDA advisory committee were former Merck employees, and Merck lobbied very heavily through political campaign contributions in Texas, where the idea of mandatory vaccinations first arose.
Conclusion and Policy Recommendations
Assuming all of those issues are adequately addressed, mandatory HPV vaccination may be a good idea for all children, and the option should be made available to adults as well. Such a program should be funded, at least in part, by government funds, and profit limitations on vaccine sales should be imposed to ensure equitable access.
References
Allen, T. J. (2008, March 7). Merck's murky dealings: HPV vaccine lobby backfires. Corpwatch: Holding Corporations Accountable. Retrieved March 26, 2008, from
Pharmaceutical News. (2008, March 5). Safety of Merck's HPV vaccine Gardasil 'lost' in debate. News-Medical.net. Retrieved March 26, 2008, from http://www.news-medical.net/?id=22415
Always verify citation format against your institution’s current style guide requirements.